Drug Profile
Research programme: anti-infective vaccines - Vaxcyte
Latest Information Update: 28 Oct 2023
Price :
$50
*
At a glance
- Originator SutroVax
- Developer Vaxcyte
- Class Conjugate vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Infections; Periodontal disorders; Streptococcal infections
Most Recent Events
- 28 Oct 2023 No recent reports of development identified for research development in Streptococcal-infections(Prevention) in USA
- 28 Mar 2023 No recent reports of development identified for preclinical development in Periodontal-disorders(Prevention) in USA
- 28 Apr 2021 No recent reports of development identified for preclinical development in Infections in USA